Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter January 1, 2011

Botulinum toxin for the treatment of pain?

Nanna Brix Finnerup and Troels Staehelin Jensen

Danish Pain Research Center, Aarhus University Hospital, Noerrebrogade 44, Building 1A, DK-8000 Aarhus C, Denmark. Tel.: +45 8949 3455, fax: +45 8949 3269

References

[1] Graff-Radford SB. Myofascial pain: diagnosis and management. Curr Pain Headache Rep 2004;8:463–7.10.1007/s11916-004-0068-ySearch in Google Scholar

[2] Aoki KR. Future aspects of botulinum neurotoxins. J Neural Transm 2008;115:567–73.10.1007/s00702-007-0758-9Search in Google Scholar

[3] Müller-Schwefe GHH, Ûberall MA. Dysport® for the treatment of myofascial back pain: results from an open-label, phase II, randomized, multicenter, doseranging study. Scand J Pain 2011;2:25–33.10.1016/j.sjpain.2010.11.002Search in Google Scholar

[4] Qerama E, Fuglsang-Frederiksen A, Jensen TS. The role of botulinum toxin in management of pain: an evidence-based review. Curr Opin Anaesthesiol 2010;23:602–10.10.1097/ACO.0b013e32833c3405Search in Google Scholar

[5] Langevin P, Lowcock J, Weber J, Nolan M, Gross AR, Peloso PM, Roberts J, Graham N, Goldsmith CH, Burnie SJ, Haines T. Botulinum toxin intramuscular injections for neck pain: a systematic review and metaanalysis. J Rheumatol 2010; (December) [Epub].10.3899/jrheum.100739Search in Google Scholar

Published Online: 2011-01-01
Published in Print: 2011-01-01

© 2010 Scandinavian Association for the Study of Pain